No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations
Open Access
- 5 June 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-14
Abstract
Frequent SARS-CoV-2 vaccination in vulnerable populations has raised concerns that this may contribute to T cell exhaustion, which could negatively affect the quality of immune protection. Herein, we examined the impact of repeated SARS-CoV-2 vaccination on T cell phenotypic and functional exhaustion in frail older adults in long-term care (n = 23), individuals on immunosuppressive drugs (n = 10), and healthy adults (n = 43), in Canada. Spike-specific CD4+ and CD8+ T cell levels did not decline in any cohort following repeated SARS-CoV-2 vaccination, nor did the expression of exhaustion markers on spike-specific or total T cells increase. T cell production of multiple cytokines (i.e. polyfunctionality) in response to the spike protein of SARS-CoV-2 did not decline in any cohort following repeated vaccination. None of the cohorts displayed elevated levels of terminally differentiated T cells following multiple SARS-CoV-2 vaccinations. Thus, repeated SARS-CoV-2 vaccination was not associated with increased T cell exhaustion in older frail adults, immunosuppressed individuals, or healthy adults.Keywords
All Related Versions
Funding Information
- Public Health Agency of Canada
- Gouvernement du Canada | Canadian Institutes of Health Research
- Population Health Research Institute and the Department of Medicine at McMaster University
This publication has 59 references indexed in Scilit:
- Early humoral and cellular responses after bivalent SARS‐CoV‐2 mRNA‐1273.214 vaccination in long‐term care and retirement home residents in Ontario, Canada: An observational cohort studyJournal of Medical Virology, 2023
- Vaccination provides superior in vivo recall capacity of SARS-CoV-2-specific memory CD8 T cellsCell Reports, 2023
- Epidemiology and Clinical Presentation of COVID-19 in Older AdultsInfectious Disease Clinics of North America, 2022
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022
- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to OmicronCell, 2022
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineCell, 2021
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19Cell, 2020
- Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)JAMA, 2020
- Properties of end-stage human T cells defined by CD45RA re-expressionCurrent Opinion in Immunology, 2012
- Activation drives PD‐1 expression during vaccine‐specific proliferation and following lentiviral infection in macaquesEuropean Journal of Immunology, 2008